echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Here comes the health insurance bureau! Should the reform of medical price bear the brunt? GPO ushers in new opportunities? Will separation of medicine speed up?

    Here comes the health insurance bureau! Should the reform of medical price bear the brunt? GPO ushers in new opportunities? Will separation of medicine speed up?

    • Last Update: 2018-06-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On May 31, the State Medical Security Bureau was officially listed Hu Jinglin, Vice Minister of the Ministry of finance, served as the director, Shi Zihai, Deputy Secretary General of the national development and Reform Commission, Chen Jinfu, director of the medical insurance Department of the Ministry of human resources and social security, and Li Tao, former director of the grass-roots Department of the national health and Family Planning Commission, served as the deputy director According to the institutional reform plan of the State Council released in March, the State Medical Security Bureau is a newly established department whose functions are integrated by the basic medical insurance and maternity insurance for urban employees and urban residents of the Ministry of human resources and social security and the new rural cooperative medical system of the health and family planning Commission Specific responsibilities include: from then on, it can be seen that the drug pricing and bidding procurement work that most affects pharmaceutical enterprises is taken over by the State Medical Security Bureau Since then, all pharmaceutical enterprises and access departments will deal with a new department around the bidding price, medical insurance payment price, medical insurance reimbursement catalog, etc For the institutional setting of the National Medical Security Bureau, the online outflow message shows that the Medical Security Bureau has eight components, including the general office, the basic medical insurance department, the agreement and regulation department, the internal control and supervision department, the information center, the clearing center, the handling center and the medical insurance Research Office In terms of functions, the Department of agreements and regulations will be responsible for the bidding of pharmaceutical equipment In addition, according to the background analysis of the leaders, the important reform measures of the medical insurance bureau in the future are likely to lie in the medical price and drug price, and many experts also put forward that the formation mechanism of the medical price is the most urgent and most successful field at present It remains to be seen whether the health insurance bureau will start from the price of drugs The following is a view on drug pricing and bidding procurement: drug price reform bears the brunt of the recent "development and governance of medical security in the new situation" forum Many experts also pointed out that the formation mechanism of drug price is the most urgent need for reform and the most successful field It is suggested that in the future, the government's pricing power for medical services and drugs should be weakened, and the government's pricing management should be gradually transformed into a market-based pricing mechanism In this context, the bidding platform is properly transformed At the same time, some experts emphasized that the corresponding reform should be based on the payment standard of medical insurance, and suggested that the payment standard should be organically linked with the dynamic adjustment of the catalogue For innovative drugs and medical technologies with great value, the negotiation method can be adopted to solve the problems of medical insurance access and payment standard determination at the same time For most new drugs that cannot be negotiated or existing generic drugs in the market, the purpose of the payment standard is not It should be to lower the price, but to adjust the price comparison between different varieties and categories of products Therefore, it is suggested that some new technical methods should be introduced to measure the current payment standard only depending on the actual sales price Important reform measures will focus on medical treatment and drug pricing From the perspective of the background of the leading personnel, the director of the State Medical Insurance Bureau was appointed by Hu Jinglin, the former head of the Ministry of finance who had served in many departments of the Ministry of Finance for 20 years and served as the Deputy ministerial post for 9 years, not by the leaders of the development and Reform Commission, the Ministry of human resources and social security, and the health and Family Planning Commission, which shows that the economic work of the medical insurance bureau is very heavy in the future A deputy director, Shi Zihai, who was in charge of policy research and price management department of the former national development and Reform Commission, said that the important reform measures of the medical insurance bureau in the future are likely to lie in the medical price and drug price Chen Jinfu, the former head of the human resources and social security department in charge of the medical insurance department, was appointed as a deputy director, explaining that the main responsibilities of the medical insurance bureau in the future are still in medical insurance Li Tao, a deputy director in charge of policy research of the former health and Family Planning Commission and the leader of the grass-roots health sector, said that the task of policy research of the medical insurance bureau in the future is very important At the same time, the grass-roots diagnosis and treatment, health care and security will be an important area of cooperation between the health care Commission and the medical insurance bureau Health Insurance Bureau brings new opportunities to GPO? After becoming the largest payer in the market, the medical insurance bureau will firmly hold the money bag "one hand out, one hand in" In order to control the rising medical expenses and balance the income and expenditure of medical insurance funds, new payment methods such as single disease payment and DRG payment will be gradually implemented The reform of medical insurance payment will undoubtedly transfer the pressure of "balancing cost and quality" in drug purchase to medical institutions, and hospitals will gradually become the main body of drug purchase It is believed that in this context, GPO, as one of the main ways for medical institutions to conduct centralized drug procurement, will usher in new development opportunities At present, China's GPO procurement has been implemented in Shanghai and Shenzhen, and some provinces and cities (such as Guangzhou, Hubei, etc.) are actively distributing Under the new medical insurance payment system, the medical insurance bureau will accelerate the separation of medicine and medicine, and the hospital's performance evaluation of doctors will inevitably change greatly: from over diagnosis and treatment, large prescription and high price medicine to reasonable diagnosis and treatment, less medicine and high price ratio medicine, which will bring better benefits to the hospital Under the incentive and constraint of the new medical insurance payment mechanism, hospitals will naturally generate endogenous motivation to reduce drug purchase price and prescribe less drugs This provides an operable policy basis for the separation of medicine However, the traditional drug marketing mode, which relies on high drug pricing and large channel space to promote sales for a long time, will also be subverted, which will have a revolutionary impact on the business behavior of drug manufacturers Statement: the content of this article is sorted out according to the platform related articles such as cypress blue, e-medicine manager, arterial network and so on The purpose is to transmit more information, which does not represent the platform's view If the content of the work, copyright and other issues are involved, please contact yaozhi.com and we will delete the content in the first time.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.